This study revealed for the first time that kallistatin was downregulated in ovarian cancer compared with fallopian tube tissues, and low expression of kallistatin was associated with unfavourable prognosis, platinum resistance and relapse in HGSOC. The gene discussed is SERPINA4; the disease is ovarian carcinoma.